Ensign Peak Advisors’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.7M Buy
2025
Q1
$8.94M Buy
2023
Q3
Sell
2023
Q2
$1.69M Hold
2023
Q1
$2.48M Buy
2022
Q4
$1.62M Sell
2022
Q3
$2.4M Buy
2022
Q2
$1.86M Buy
2022
Q1
$286K Buy